Genetics of Huntington disease

American Journal of Neuroradiology

Volumn 35, Issue 6, 2014, Pages 1070-1072

  Mahalingam, S ^a   Levy, Lucien M ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; HUNTINGTIN; HTT PROTEIN, HUMAN; NERVE PROTEIN;

ALLELE; CAG REPEAT; DIAGNOSTIC TEST; DIFFUSION TENSOR IMAGING; FUNCTIONAL NEUROIMAGING; GENETICS; HUMAN; HUNTINGTON CHOREA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTION; PROTEIN FUNCTION; SEX DIFFERENCE; SHORT SURVEY; BRAIN; DIAGNOSTIC IMAGING; GENETIC PREDISPOSITION; HUNTINGTON DISEASE; PATHOLOGY; PROCEDURES; RADIOGRAPHY; SINGLE NUCLEOTIDE POLYMORPHISM;

BRAIN; DIAGNOSTIC IMAGING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNTINGTON DISEASE; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84902331318     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3772     Document Type: Short Survey

References (15)

1. Bates GP. History of genetic disease: the molecular genetics of Huntington disease: a history. Nat Rev Genet 2005;6:766-73 (Pubitemid 41400834)
2. Ross CA, Tabrizi SJ. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011;10:83-98
3. Myers RH. Huntington's disease genetics. NeuroRx 2004;1:255- 62
4. Borrell-Pagès M, Zala D, Humbert S, et al. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci 2006;63:2642-60
5. Walker FO. Huntington's disease. Lancet 2007;369:218-28 (Pubitemid 46107685)
6. Koutsis G, Karadima G, Kladi A, et al. The challenge of juvenile Huntington disease: to test or not to test. Neurology 2013;80:990 -96
7. Trottier Y, Devys D, Imbert G, et al. Cellular localization of the Huntington's disease protein and discrimination of the normal andmutated form. Nat Genet 1995;10:104-10
8. Bates G. Huntingtin aggregation and toxicity in Huntington's disease. Lancet 2003;361:1642-44 (Pubitemid 36579005)
9. Semaka A, Creighton S, Warby S, et al. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet 2006;70:283-94 (Pubitemid 44323391)
10. Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009;8:791-801
11. Klöppel S, Henley SM, Hobbs NZ, et al. Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience 2009;164:205-19
12. Shin H, Kim MH, Lee SJ, et al. Decreased metabolism in the cerebral cortex in early-stage Huntington's disease: a possible biomarker of disease progression? J Clin Neurol 2013;9:21-25
13. Versluis MJ, van der Grond J, van Buchem MA, et al. High-field imaging of neurodegenerative diseases. Neuroimaging Clin N Am 2012;22:159-71, ix
14. Bohanna I, Georgiou-Karistianis N, Sritharan A, et al. Diffusion tensor imaging in Huntington's disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits. Brain Imaging Behav 2011;5:171-80
15. Rosas HD, Tuch DS, Hevelone ND, et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relationship to clinical measures. MovDisord 2006;21:1317-25 (Pubitemid 44613279)